|
Novo Nordisk News is an EIN News Service for health professionals. Constantly updated news and information about health.
- Diabetes cases to double, costs to triple by 2034 28 Nov 2009 18:46 GMT
... in the health care system, particularly to Medicare. The National Changing Diabetes Program of Novo Nordisk, a maker of insulin, funded the study. "The public policy implications are enormous," said ...
- Diabetes Population to Double and Diabetes Costs to Nearly Triple in 25 Years, New Study Shows 27 Nov 2009 20:32 GMT
... to a study published in the December issue of Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago. According to the ...
- Olympia Dukakis and Louis Zorich Publicize Free Diabetes Screening 27 Nov 2009 20:32 GMT
... to get tested. But their efforts didn’t stop there. Olympia and Louis partnered with Novo Nordisk to launch a national educational program to increase awareness of diabetes, increase utilization of ...
- Phase Forward to Present at the 21st Annual Piper Jaffray Health Care Conference 27 Nov 2009 16:11 GMT
... the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and ...
- Diabetes To Become More Prevalent, Expensive By 2034 27 Nov 2009 15:45 GMT
... will exceed current projections of total Medicare spending. The National Changing Diabetes Program of Novo Nordisk, a maker of insulin, funded the study. The University of Chicago investigators are co-investigators ...
- Diabetes Care Will Cost $336B by 2034 27 Nov 2009 15:12 GMT
... received support for this project as consultants to the National Changing Diabetes Program of Novo Nordisk. No other potential conflicts of interest were reported. ...
- Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows / Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care 27 Nov 2009 14:54 GMT
... December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago. According to the ...
- Study: Cost of treating diabetes to triple by 2034 27 Nov 2009 11:42 GMT
... discoveries have driven costs up, not down." The study was funded by the company Novo Nordisk, which makes insulin delivery systems to treat diabetics. Novo Nordisk approved the final manuscript, ...
- Researchers predict diabetes cases to double and cost to triple in the next 25 years 27 Nov 2009 06:39 GMT
... a study published in the December issue of ® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago. According to the ...
- Diabetes cases to double and costs to triple by 2034 27 Nov 2009 06:15 GMT
... will exceed current projections of total Medicare spending. The National Changing Diabetes Program of Novo Nordisk, a maker of insulin, funded the study. The University of Chicago investigators are co-investigators ...
- Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 27 Nov 2009 05:30 GMT
... a study published in the December issue of ® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago. According to the ...
- Clinical Trials in Russia. 3rd Quarter 2009. 26 Nov 2009 18:35 GMT
... of the heap in the third quarter of 2009. The Danish top five “debutant” Novo Nordisk with six new trials in Q3 2009 took the runner-up place. It is followed ...
- Research and Markets: Osteoporosis Therapeutics - a Global Market Perspective: the Most Comprehensive Report in Geographic Coverage and Vertical Market Analyses 26 Nov 2009 15:14 GMT
... Roche Ltd (Switzerland) -- Merck & Co., Inc. (US) -- Novartis AG (Switzerland) -- Novo Nordisk A/S (Denmark) -- Organon -- Procter & Gamble Pharmaceuticals Inc. (US) -- Sanofi-Aventis SA ...
- November 14 is World Diabetes Day 26 Nov 2009 14:32 GMT
... Boston Scientific, Bristol-Myers Squibb, LifeScan, Eli Lilly, Medtronic, Merck Sharp & Dohme (MSD), Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis and Takeda. (1) IDF Diabetes Atlas 4th Edition, International Diabetes ...
- Rituximab Protects Insulin Producing Cells in Diabetes 25 Nov 2009 23:19 GMT
... has had relationships with Merck, sanofi aventis, Takeda Pharmaceuticals, Eli Lilly & Co., and Novo Nordisk. Greeley reported no potential conflicts of interest. This article was developed in collaboration with ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
nytimes.com:
bbc.co.uk:
guardian.co.uk:
msnbc.msn.com: